Furthermore, glucose reduction (via inhibition of the sodium-glucose like transporter 2) improved β cell function and suppressed islet CCK expression and tumor development in the KCO model (Chung et al, 2020), arguing that interventions that attenuate obesity-induced β cell stress may subvert tumorigenesis. Here, CCK is linked to obesity disorder.